“Triaditis” is a common diagnosis in the cat, and yet, there is a paucity of literature documenting the existence of this disease as a distinct clinical entity. There are however a plethora of studies describing the separate components of this disease. Indeed post mortem studies describing cholangitis in the cat have documented concurrent IBD in 83% and 50% of cases, pancreatitis in 50% and 60% of cases and both in 39% and 32% of cases. Furthermore, those describing pancreatitis have shown an increased pancreatic score (a measure of pancreatic inflammation) in cats with GI disease (including liver disease) compared to healthy animals. Recently, a clinical case series has documented concomitant small bowel IBD, cholangitis and pancreatiis in 30% (10/33) cats undergoing exploratory coeliotomy; concomitant small bowel IBD and cholangitis in 30% of cases, and pancreatic and GI inflammation in 12% of cases. Taken together, there seems little doubt that cats have a tendency to succumb to 2 or more of these entities; so what are we missing and why are there no clinical studies of cats with Triaditis? This webinar will discuss the clinical syndrome and clinical signs, what is known and what we have yet to learn.
In case you have missed this webinar, you have the opportunity to watch a recorded version here
*While we consistently and constantly strive to deliver the highest quality webinars for our loyal customers, this webinar in particular has a few audio issues. We considered taking it offline, but because the subject matter is so important, we decided to allow it to remain online!
Speaker:
Kerry Simpson
BVM&S, CertVC, PhD, MACVSc, MRCVS
